Viewing Study NCT01427920


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT01427920
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2011-08-31
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization: